Back to search

Article

ILA-producing Lacticaseibacillus paracasei NCU-21 exerts anti-acute myeloid leukemia effects by inhibiting the PI3K-AKT pathway

2026-08-18

Abstract excerpt

Cytarabine (Ara-C) remains the cornerstone of induction therapy for acute myeloid leukemia (AML). However, its overall clinical efficacy is suboptimal, and the regimen is frequently accompanied by severe disruption of intestinal homeostasis. Consequently, identifying novel adjunctive therapies to improve treatment outcomes represents a critical clinical need. Gut microbiome profiling in AML mouse models reveals th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b643d576-71be-5d09-9bfb-29090a3c82ff
DOI
10.1186/s13059-026-04225-5
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ILA-producing Lacticaseibacillus paracasei NCU-21 exerts anti-acute myeloid leukemia effects by inhibiting the PI3K-AKT pathwayDOI 10.1186/s13059-026-04225-5
Select a neighboring publication to make it the new centre.